Skip to main content

Advertisement

Table 2 Correlation between CXCR7 expression and clinicopathological data

From: CXCR7 expression in esophageal cancer

  CXCR7 primary tumor (ESCC)  
  Total CXCR7 negative CXCR7 positive p-value
   (n=87, 55%) (n=72, 45%)  
Median Age, years (range) 159 60.9 (36–80) 62.1 (37–93) 0.158
Sex        
  Female 119 70 (59%) 49 (41%)  
  Male 40 17 (43%) 23 (57%) 0.098
Disease Stage (UICC 7th edition)       
  T 1 23 15 (65%) 8 (35%)  
   2 33 18 (55%) 15 (45%)  
   3 91 47 (52%) 44 (48%)  
   4 12 7 (58%) 5 (42%) 0.698
  N 0 67 36 (54%) 31 (46%)  
   1-3 92 51 (55%) 41 (45%) 0.873
  M 0 158 86 (54%) 72 (46%)  
   1 1 1 (100%) 0 (0%) 1.000
  G 1 4 2 (50%) 2 (50%)  
   2 113 60 (53%) 53 (47%)  
   3 42 25 (59%) 17 (41%) 0.761
Prognostic Tumor Staging (UICC 7th edition)
  Ia°   19 12 (63%) 7 (37%)  
  Ib°   16 8 (50%) 8 (50%)  
  IIa°   28 14 (50%) 14 (50%)  
  IIb°   13 8 (61%) 5 (39%)  
  IIIa°   40 21 (52%) 19 (47%)  
  IIIb°   20 10 (50%) 10 (50%)  
  IIIc°   22 13 (59%) 9 (41%)  
  IV°   1 1 (100%) 0 (0%) 0.931
Bone marrow micrometastasis       
  Negative 61 34 (56%) 27 (44%)  
  Positive 34 17 (50%) 17 (50%) 0.670
CXCR7 status       
  LN Negative 32 17 (53%) 15 (47%)  
   Positive 20 9 (45%) 11 (55%) 0.776
  Met Negative 6 4 (67%) 2 (33%)  
   Positive 8 4 (50%) 4 (50%) 0.627
CXCR4 status       
  PT Negative 17 12 (71%) 5 (29%)  
   Positive 29 13 (45%) 16 (55%) 0.128